Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 43 results
Start Over Descriptor "Antiviral agents -- Product introduction" Topic pharmaceutical industry -- product introduction
43 results on '"Antiviral agents -- Product introduction"'

1. New COVID-19 treatment from Merck could reduce hospitalizations and deaths

Subjects
Merck & Company Inc. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, General interest
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=1042667282 BYLINE: JOE PALCA HOST: SCOTT SIMON SCOTT SIMON: The United States has seen another grim mark in this pandemic. More than 700,000 [...]

Published
2021

2. Selected new drugs of 1996

Author

Hussar, Daniel A.

Subjects
Antiviral agents -- Product introduction, Anti-infective agents -- Product introduction, Hypoglycemic agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Health care industry, Retail industry, Product introduction
Abstract

A review of agents that treat HIV, infection, diabetes and ALS In this second part of a two-part series on selected new drugs that have been marketed in 1996, the [...]

Published
1996

3. Clinical News: Treatment launched for hepatitis

Subjects
Novartis Pharma AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis B -- Drug therapy, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Sebivo (Medication) -- Product introduction
Abstract

Novartis Pharmaceuticals has launched a treatments for hepatitis B. Telbivudine (Sebivo) is licensed for the treatment of chronic hepatitis B in adults with compensated liver disease, evidence of viral replication, [...]

Published
2007

4. Telzir Oral Suspension

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

GlaxoSmithKline has launched Telzir (fosamprenavir) 50mg/ml Oral Suspension. It is licensed in combination with low dose ritonavir for the treatment of HIV in adults over 18 years old. It should [...]

Published
2004

5. New Drugs 2001 Part III

Author

HUSSAR, DANIEL A.

Subjects
Pharmaceutical industry -- Product introduction, Anticoagulants (Medicine) -- Product introduction, Antiviral agents -- Product introduction, Abortifacients -- Product introduction, Antineoplastic agents -- Product introduction, Local anesthesia -- Product introduction, Anticholesteremic agents -- Product introduction, Health
Published
2001

6. NEW DRUGS

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Organon Inc. -- Product introduction -- Laws, regulations and rules, Salix Pharmaceuticals -- Product introduction, Axcan Scandipharm Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules, Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules, Hepatitis -- Laws, regulations and rules, Antiviral agents -- Product introduction, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Oral contraceptives -- Product introduction, Government regulation, Business, Pharmaceuticals and cosmetics industries, Cyclessa (Contraceptive) -- Product introduction, Colazal (Medication) -- Product introduction, Canasa (Medication) -- Product introduction, Peg-Intron (Medication) -- Product introduction
Abstract

Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]

Published
2001

7. UK drug update

Subjects
Novo Nordisk Pharmaceuticals Inc. -- Product introduction, Janssen-Cilag -- Product introduction, Sanofi Winthrop GmbH -- Product introduction, Dermal Laboratories Ltd. -- Product introduction, Ferring Pharmaceuticals -- Product introduction, Organon Laboratories (UK) -- Product introduction, Rosemont Pharmaceutical Corp. -- Product introduction, Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Product introduction, Hormones, Antiviral agents -- Product introduction, Hypoglycemic agents, Respiratory system agents, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Contraceptives -- Product introduction, Respiratory agents
Abstract

Novo Nordisk Pharmaceuticals has introduced Novorapid injections. The vials, Penfill cartridges and Novolet prefilled syringe contain insulin aspart 100 units/ml. Dermal Laboratories has brought out an antimicrobial bath emollient. The [...]

Published
1999

8. From antivirals to Viagra: drug review of '98

Subjects
Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Cardiovascular agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1999

9. New edition of WHO prequalification list to include four new anti-aids medicines

Subjects
Lamivudine -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Science and technology, Product introduction
Abstract

Four new AIDS medicines are being added to the World Health Organization (WHO) prequalification list, thus further increasing access to a choice of quality products. At the same time, product [...]

Published
2004

10. Companies sock away swine meds; Exelon among firms loading up on anti-virals

Author

Colias, Mike and Saphir, Ann

Subjects
Exelon Corp. -- Product introduction, Antiviral agents -- Product introduction, Swine influenza -- Control, Pharmaceutical industry -- Product introduction, Business, Business, regional
Abstract

Fearing a flu pandemic, some Chicago companies are stockpiling influenza-fighting drugs. Exelon Corp. has stashed thousands of doses of anti-viral medications such as Tamiflu for employees and their dependents in [...]

Published
2009

11. New drugs of 1986

Author

Hussar, Daniel A.

Subjects
Drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Pediculosis -- Care and treatment, Antiviral agents -- Product introduction, Anti-arrhythmia drugs -- Product introduction, New products -- Analysis, Business, Health care industry, Pharmaceuticals and cosmetics industries, Retail industry
Published
1986

12. South Africa's Aspen unveils anti-AIDS drug

Subjects
Aspen Pharmacare Holdings Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Generic drugs -- Product introduction, Business, Business, general
Published
2003

13. New products in 1994

Author

Hughes, Susan

Subjects
Genentech Inc. -- Product introduction, Roche Holding Ltd. -- Product introduction, Pfizer Inc. -- Product introduction, Upjohn Co. -- Product introduction, Hoechst AG -- Product introduction, Cystic fibrosis -- Drug therapy, Rheumatoid arthritis -- Drug therapy, Subarachnoid hemorrhage -- Drug therapy, Antidepressants -- Product introduction, Alzheimer's disease -- Drug therapy, Antiviral agents -- Product introduction, Immunosuppressive agents -- Product introduction, Antineoplastic agents -- Product introduction, Cardiovascular agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Product introduction, Tenidap (Medication) -- Product introduction, Freedox (Medication) -- Product introduction, Velnacrine (Medication) -- Product introduction
Published
1994

14. Cold sores affect millions

Author

Cassell, Dana K.

Subjects
Cold sores -- Causes of, Cold sores -- Drug therapy, Herpes simplex -- Causes of, Herpes simplex -- Drug therapy, Antiviral agents -- Product introduction, Herpes simplex virus -- Health aspects, Herpes simplex virus -- Research, Pharmaceutical industry -- Product introduction
Abstract

In ancient Rome, an epidemic of cold sores (also known as fever blisters) prompted Emperor Tiberius to ban kissing in public ceremonies. Today, cold sores continue to present in epidemic [...]

Published
2009

15. Reese rollout

Subjects
Reese Pharmaceutical Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, OneTab (Medication) -- Product introduction
Abstract

Reese Pharmaceutical Co. has introduced a line of three O-T-C dye-flee cold- and flu-relief tablet products. Marketed under the brand name OneTab, the individual product offerings are for cold and [...]

Published
2009

16. Roche

Subjects
Roche Holding AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, Tamiflu (Medication) -- Product introduction
Abstract

Ample supplies of the flu medication Tamiflu will be available throughout the United States during flu season, manufacturer Roche stated. The Centers for Disease Control and Prevention has cited Tamiflu [...]

Published
2008

17. Lexiva oral suspension

Subjects
GSK PLC -- Product introduction, Antiviral agents -- Product introduction, Fosamprenavir -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Lexiva (Medication) -- Product introduction
Abstract

An oral suspension formulation of GlaxoSmithKline's protease inhibitor Lexiva (fosamprenavir calcium) has been made available for the treatment of patients 2-18 years of age infected with HIV. The 50mg/mL strength [...]

Published
2007

18. Abbott urged to provide new version of Kaletra to poor countries

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product enhancement, Abbott Laboratories (Abbott Park, Illinois) -- International marketing, Alternative medicine -- International marketing, Antiviral agents -- Product introduction, Antiviral agents -- International marketing, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- International marketing, Product enhancement, Business, Pharmaceuticals and cosmetics industries
Abstract

A non-governmental organization, Medecins sans Frontieres, has asked Abbott Laboratories to introduce a new version of its antiretroviral drug, Kaletra (lopinavir plus ritonavir) for sale in poor and developing countries.

Published
2006

19. PS debut

Subjects
Antibacterial agents -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

American HomeHealth Inc. has created an 'infection prevention' category with its debut of PS. The brand incorporates a number of antiviral and antibacterial products to help consumers with their cleaning [...]

Published
2006

20. Colorado Serum Co

Subjects
Colorado Serum Co. -- Product introduction, Antiviral agents -- Product introduction, Veterinary drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Agricultural industry, Business, Product introduction
Abstract

Colorado Serum Co., Denver, Colo., introduced its West Nile Virus Antibody-Equine Origin for use as an aid in the control of disease due to West Nile virus in horses. The [...]

Published
2005

21. HIV drug approved

Subjects
Hoffmann-La Roche Inc. -- Product introduction, Fuzeon (Medication) -- Product introduction, Pharmaceutical industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents -- Product introduction
Abstract

Fuzeon (enfuvirtide) is approved for injection, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy. [...]

Published
2004

22. Combination HIV-1 drug approved

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction
Abstract

Epzicom (abacavir/lamivudine) is approved for the treatment of HIV-1 infection. The formulation is a fixed-dose combination of the antiretroviral drugs abacavir sulfate (600 mg) and lamivudine (300 mg). For more [...]

Published
2004

23. Geneva Pharmaceuticals

Author

Frederick, James

Subjects
Geneva Pharmaceuticals Inc. -- Product introduction, Hepatitis C -- Care and treatment, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Last month, Geneva Pharmaceuticals announced that it is moving ahead with its generic production of Schering-Plough's Rebetol (ribavirin), a hepatitis C treatment that generated $721 million in sales for the [...]

Published
2003

24. Ranbaxy launches abacavir in India

Subjects
Ranbaxy Laboratories Ltd. -- Product introduction, Ranbaxy Laboratories Ltd. -- Product information, Pharmaceutical industry -- Product information, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antiviral agents -- Product information, Business, Pharmaceuticals and cosmetics industries
Abstract

Ranbaxy Laboratories' abacavir antiretroviral drug has been launched in India. The drug is marketed under the Virol brand name. It is the generic version of GlaxoSmithKline's Ziagen drug.

Published
2003

25. Roche Products. (UK Drug Update)

Subjects
Roche Products Ltd. -- Product introduction, Influenza -- Drug therapy, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Tamiflu (Medication) -- Product introduction
Published
2003

26. China makes its first antiretroviral drugs for treating AIDS. (News)

Author

Parry, Jane

Subjects
Shanghai Desano Biopharmaceutical Co. -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Product introduction
Abstract

China's first domestically produced combination drug treatment for AIDS is due to go on sale by the end of 2002, after the manufacturer, Shanghai Desano Biopharmaceuticals Company, based in Shanghai, [...]

Published
2002

27. Current Trends and Growth Indications in the Global Anti-Infectives Market to 2011

Subjects
Marketing research, Company growth, Pharmaceutical industry -- Market research, Pharmaceutical industry -- Industry forecasts, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- Reports, Pharmaceutical industry -- Growth, Antiviral agents -- Market research, Antiviral agents -- Product introduction, Antiviral agents -- Reports, Antiviral agents -- Growth
Abstract

Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is now available to its catalogue. The Global Anti-Infectives Market Outlook to 2011 http://www.reportlinker.com/p051035/anti-infectives .html The [...]

Published
2007

28. More generic drugs wanted by Thailand

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

In response to the decision by US drugmaker Abbott Laboratories to boycott Thailand's market for new drugs, itself a reaction to an earlier government decision to issue compulsory licenses against [...]

Published
2007

29. Open BioSystems debuts Lentiviral shRNAmir library

Subjects
Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

Open Biosystems, a US firm focused on the commercialization of leading-edge life science research tools for drug discovery, has announced the availability of its lentiviral microRNA-adapted short hairpin RNA (shRNAmir) [...]

Published
2006

30. Ranbaxy India launches high compliance ARVs

Subjects
Ranbaxy Laboratories Ltd. -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries, Virolis-E (Medication) -- Product introduction
Abstract

Indian drugs giant Ranbaxy Laboratories has introduced two new anti-HIV products, Virolis-E and Virocomb-E. Both products contain three anti-retroviral drugs and offer World Health Organization-recommended first-line highly-active anti-retroviral Therapy in [...]

Published
2005

31. 1st launch of B Ingelheim's nevirapine

Subjects
Boehringer Ingelheim GmbH -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Viramune (Medication) -- Product introduction
Published
1996

32. UK launch of oral ganciclovir

Subjects
Roche Holding Ltd. -- Product introduction -- 00401302, Pharmaceutical industry -- Product introduction, Cytomegalovirus infections -- Drug therapy, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Cymevene (Medication) -- Product introduction
Published
1995

33. Gilead's new antivirals

Subjects
Gilead Sciences Inc. -- Product introduction -- 00223651, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Published
1995

34. First launches of Wellcome's Valtrex

Subjects
Wellcome PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Valtrex (Medication) -- Product introduction
Published
1995

35. Famvir's launch in the US

Subjects
SmithKline Beecham Corp. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

36. 1st launch for SB's famciclovir - the UK

Subjects
United Kingdom -- Health aspects, SmithKline Beecham Corp. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

37. Drugs offer hope - at a price: financial squeeze on AIDS programs threatens access

Author

Shelton, Deborah L.

Subjects
AIDS (Disease) -- Care and treatment, Antiviral agents -- Product introduction, Protease inhibitors -- Product introduction, Pharmaceutical industry -- Product introduction, Health
Abstract

Four new antiretroviral drugs have been approved for the treatment of AIDS, including Saquinavir, which is one of three approved protease inhibitors. However, medication costs have skyrocketed, leaving over 50% of those with AIDS depending on drug industry programs or public health programs. AIDS therapy can run as high as $18,000 wholesale, while a year's worth of a protease inhibitor costs approximately $5,560., Financial squeeze on AIDS programs threatens access The U.S. Food and Drug Administration's approval in recent weeks of four new antiretroviral drugs, including three protease inhibitors, offers hope to people [...]

Published
1996

38. Videx launched in Japan

Subjects
Bristol-Myers Squibb Co. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Videx (Medication) -- Product introduction
Published
1992

39. Mochida launches vidarabine for herpes in Japan

Subjects
Mochida Pharmaceutical Company Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Arasena-A (Medication) -- Product introduction
Published
1992

40. Agouron girds to join AIDS-drug battle: biotech firm's Viracept is a pricey late entry

Author

Rundle, Rhonda L.

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, AIDS (Disease) -- Drug therapy, Banking, finance and accounting industries, Business, Business, international, Viracept (Medication) -- Product introduction
Published
1997

41. Drug available for treatment of recurrent genital herpes

Subjects
SmithKline Beecham Corp. -- Product introduction -- 00307917, Famvir (Medication) -- Product introduction, Antiviral agents -- Product introduction, Herpes genitalis -- Drug therapy, Pharmaceutical industry -- Product introduction
Abstract

SmithKline Beecham, Philadelphia, Pennsylvania, announced that Famvir (famciclovir) is available nationwide to Treat genital herpes. Famvir, an antiviral drug that requires less frequent dosing than the medication commonly used to [...]

Published
1996

42. Hepatitis A vaccine - licence potential?

Subjects
Pasteur Merieux Serums et Vaccins S.A. -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis A -- Drug therapy, Vaccines -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries, Avaxim (Medication) -- Product introduction
Abstract

Pharmaceutical joint venture Pasteur Merieux has launched its Avaxin hepatitis A vaccine in the U.K.. The company had been expected to introduce Vaqta, which has received licenses in the U.S. and Germany. Pasteur Merieux's director of business relations says that the two vaccines are very similar.

Published
1996

43. Interferon approvals usher in biodrug era

Author

Robinson, Bill

Subjects
Hoffmann-La Roche Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction, Interferon -- Product introduction, Pharmaceutical industry -- Product introduction, Leukemia -- Care and treatment, Antiviral agents -- Product introduction
Abstract

Interferon approvals usher in biodrug era The recent approval of interferon produced by genetic engineering sparked an unusual excitement as the new age of biotherapeautics became suddenly real in the [...]

Published
1986

Catalog

Books, media, physical & digital resources
See catalog results